Suberoylanilide hydroxamic acid b-D-glucuronide
CAS: 863456-50-2
Ref. 3D-MS07390
10mg | 3.598,00 € | ||
25mg | 7.495,00 € | ||
50mg | 12.491,00 € |
Información del producto
- 1-O-[[1,8-Dioxo-8-(phenylamino)octyl]amino]-b-D-Glucopyranuronic acid
- 1-O-[[1,8-Dioxo-8-(phenylamino)octyl]amino]-b-D-glucopyranuronic Acid
- Suberoylanilide Hydroxamic Acid b-D-Glucuronide
- 1-O-[[1,8-Dioxo-8-(phenylamino)octyl]amino]--D-glucopyranuronic Acid
- Suberoylanilide Hydroxamic Acid -D-Glucuronide
Suberoylanilide hydroxamic acid b-D-glucuronide (SAHA) is a histone deacetylase inhibitor that is used in the treatment of colorectal adenocarcinoma. It is orally administered and can cross the blood-brain barrier to inhibit HDACs in human liver cells. SAHA has been shown to be effective against a number of cancer cell lines, including colon, prostate, breast, lung, and leukemia cell lines. SAHA has also been shown to have clinical benefits in various cancers and has been found to be safe at doses up to 1g/day when given for 24 months. The most common side effects are thrombocytopenia and anorexia.
Propiedades químicas
Consulta técnica sobre: 3D-MS07390 Suberoylanilide hydroxamic acid b-D-glucuronide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.